Similar articles

• A polypill strategy to improve adherence: results from the FOCUS project.

  Castellano JM, Sanz G, Peñalvo JL, Bansilal S, Fernández-Ortiz A, Alvarez L, Guzmán L, Linares JC, García F, D'Aniello F, Arnáiz JA, Varea S, Martínez F, Lorenzatti A, Imaz I, Sánchez-Gómez LM, Roncaglioni MC, Baviera M, Smith SC Jr, Taubert K, Pocock S, Brotons C, Farkouh ME, Fuster V. Castellano JM, et al. J Am Coll Cardiol. 2014 Nov 18-25;64(20):2071-82. doi: 10.1016/j.jacc.2014.08.021. Epub 2014 Sep 1. J Am Coll Cardiol. 2014. PMID: 25193393 Clinical Trial.
• Maximizing therapeutic envelope for prevention of cardiovascular disease: role of polypill.

  Sanz G, Fuster V. Sanz G, et al. Mt Sinai J Med. 2012 Nov-Dec;79(6):683-8. doi: 10.1002/msj.21355. Mt Sinai J Med. 2012. PMID: 23239207 Review.
• [Health and longevity by one tablet daily. Fiction and hard facts on the polypill].

  Holzgreve H. Holzgreve H. MMW Fortschr Med. 2014 Jan 20;156(1):55-7. MMW Fortschr Med. 2014. PMID: 24930311 Review. German. No abstract available.
• A polypill strategy to improve global secondary cardiovascular prevention: from concept to reality.

  Castellano JM, Sanz G, Fernandez Ortiz A, Garrido E, Bansilal S, Fuster V. Castellano JM, et al. J Am Coll Cardiol. 2014 Aug 12;64(6):613-21. doi: 10.1016/j.jacc.2014.06.009. J Am Coll Cardiol. 2014. PMID: 25104532 Review.
• The polypill: a potential global solution to cardiovascular disease.

  Nguyen C, Cheng-Lai A. Nguyen C, et al. Cardiol Rev. 2013 Jan-Feb;21(1):49-54. doi: 10.1097/CRD.0b013e3182755429. Cardiol Rev. 2013. PMID: 23018668 Review.